Spatial profiling studies in TNBC identified a “fully inflamed” TIME subtype marked by tumor-core CD8+ T cells, granzyme B positivity, type I IFN signatures, and MHC I expression—hallmarks of immune activation and checkpoint responsiveness [48]. Here, CD8A is linked to neoplasm.